Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Deregulated expression of A1, Bcl-2, Bcl-x(L), and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients

Full text
Show less -
Lino Gasparotto, Elainy Patricia [1] ; Tognon, Raquel [1] ; Ferreira, Aline Fernanda [1] ; Vilela Oliveira, Gislane Lelis [1] ; Bonini Palma, Patricia Vianna [2] ; Zanichelli, Maria Aparecida [3] ; Souto, Elizabeth Xisto [3] ; Engel Velano, Carlos Eduardo [4] ; Simoes, Belinda Pinto [4] ; Viu Carrara, Rita de Cassia [2] ; Kashima, Simone [2] ; Covas, Dimas Tadeu [2, 4] ; de Castro, Fabiola Attie [1] ; de Souza, Ana Maria [1]
Total Authors: 14
[1] USP, Dept Clin Anal Toxicol & Food Sci, Fac Pharmaceut Sci Ribeirao Preto, BR-14040903 Ribeirao Preto, SP - Brazil
[2] USP, Hemotherapy Ctr Ribeirao Preto, Sch Med Ribeirao Preto, BR-14040903 Ribeirao Preto, SP - Brazil
[3] Brigadeiro Hosp, Sao Paulo - Brazil
[4] USP, Dept Clin Med, Fac Med Ribeirao Preto, BR-14040903 Ribeirao Preto, SP - Brazil
Total Affiliations: 4
Document type: Journal article
Source: Brazilian Journal of Pharmaceutical Sciences; v. 47, n. 4, p. 873-886, OCT-DEC 2011.
Web of Science Citations: 6

Apoptosis deregulation might have a role in the pathophysiology of polycythemia vera (PV). This study evaluated Bcl-2 molecule expression in CD34(+) cells and leukocytes in 12 PV patients. Gene expression was investigated by real time PCR using SybrGreen Quantitect kit and protein expression was evaluated by western-blotting. JAK2 V617F mutation was detected according to Baxter et al (2005). CD34(+) cells from PV patients presented higher levels of A1 and Mc1-1 expression (median: 22.6 and 5.2, respectively) in comparison with controls (0.9 and 0.5, p=0.004 and p=0.020); while Bcl-2 and Bcl-x(L) expression decreased in PV patients (0.18 and 1.19) compared with controls (1.39 and 2.01, p=0.006 and p=0.020). CD34(+) cells in PV patients showed an elevated Bid expression (14.4) in comparison with healthy subjects (1.0; p=0.002). Patients' leukocytes showed an A1 augmentation (7.41, p=0.001) and a reduced expression of Bar (0.19; p=0.040) and Bad (0.2; p=0.030). There was no correlation between JAK2 V617F allele burden and molecular expression. PV patients showed alterations in Bcl-2 members' expression, which may interfere with control of apoptotic machinery and contribute to disease pathogenesis. (AU)